Helset E, Kjaeve J, Bjertnaes L, Lundberg J M
Department of Anaesthesiology, University of Tromsø, Norway.
Scand J Clin Lab Invest. 1995 Aug;55(5):369-76. doi: 10.3109/00365519509104975.
The release and vascular effects of calcitonin gene-related peptide (CGRP) and endothelin-1 (ET-1) during acute alveolar hypoxia (O2 2%) were examined in isolated blood-perfused rat lungs. In 10 lungs, repeatedly ventilated with hypoxic gas for 5 min, samples from effluent blood were taken during hypoxia and analysed for plasma levels of CGRP-like immunoreactivity (-LI) and ET-1-LI. The plasma levels of ET-1-LI were significantly (p < 0.05) increased in hypoxic lungs (5.5 +/- 0.5 pmol l-1) compared with normoxic controls (3.7 +/- 0.56 pmol l-1). Plasma levels of CGRP-LI were significantly (p < 0.01) lower in hypoxic lungs (43.9 +/- 2.9 pmol l-1) than in normoxic controls (55.5 +/- 4.0 pmol l-1). No significant correlation was seen between perfusate peptide levels and pulmonary artery pressure (Ppa) during ventilation with normoxic or hypoxic gas. Infusion of the CGRP receptor blocker, CGRP, did not influence either the baseline Ppa or the development of the hypoxic pulmonary vasoconstriction response (HPV). In lungs undergoing HPV, 2 nmol l-1 ET-1 added to the perfusate, significantly reduced the hypoxic pressor response by 14 +/- 3% (p < 0.05), while addition of 200 nmol l-1 ET-1 caused no significant changes in HPV. CGRP 2 nmol l-1 caused no significant attenuation of HPV (8.9%), while 200 nmol l-1 CGRP significantly reduced HPV by 16 +/- 5% (p < 0.05). To conclude: acute alveolar hypoxia changes release of CGRP and ET-1 to the perfusate in isolated rat lungs. The results further suggest that CGRP and ET-1 are not involved in the development and regulation of the hypoxic pulmonary vasoconstriction response.
在离体血液灌注大鼠肺中,研究了急性肺泡缺氧(氧含量2%)期间降钙素基因相关肽(CGRP)和内皮素-1(ET-1)的释放及其血管效应。对10只大鼠肺用低氧气体反复通气5分钟,在缺氧期间采集流出血液样本,分析血浆中CGRP样免疫反应性(-LI)和ET-1-LI水平。与常氧对照组(3.7±0.56 pmol l-1)相比,缺氧肺中ET-1-LI的血浆水平显著升高(p<0.05)(5.5±0.5 pmol l-1)。缺氧肺中CGRP-LI的血浆水平(43.9±2.9 pmol l-1)显著低于常氧对照组(55.5±4.0 pmol l-1)(p<0.01)。在常氧或低氧气体通气期间,灌注液中肽水平与肺动脉压(Ppa)之间未观察到显著相关性。注入CGRP受体阻滞剂CGRP,既不影响基线Ppa,也不影响缺氧性肺血管收缩反应(HPV)的发展。在发生HPV的肺中,向灌注液中添加2 nmol l-1 ET-1可使缺氧性升压反应显著降低14±3%(p<0.05),而添加200 nmol l-1 ET-1对HPV无显著影响。2 nmol l-1 CGRP对HPV无显著减弱作用(8.9%),而200 nmol l-1 CGRP可使HPV显著降低16±5%(p<0.05)。结论:急性肺泡缺氧改变了离体大鼠肺灌注液中CGRP和ET-1的释放。结果进一步表明,CGRP和ET-1不参与缺氧性肺血管收缩反应的发生和调节。